Predictors of successful short-term tobacco cessation in UK resident female Bangladeshi tobacco chewers

Addiction

Volumn 107, Issue 7, 2012, Pages 1354-1358

  Croucher, Ray ^a   Shanbhag, Siddharth ^a   Dahiya, Manu ^a   Kassim, Saba ^a   Mcneill, Ann ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Bangladeshi; Smokeless tobacco cessation; Women

Indexed keywords

NICOTINE GUM;

ARTICLE; BANGLADESH; BEHAVIOR THERAPY; ETHNOLOGY; FEMALE; HUMAN; MIDDLE AGED; ONSET AGE; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SMOKELESS TOBACCO; SMOKING CESSATION; STATISTICS; TREATMENT OUTCOME; UNITED KINGDOM;

AGE OF ONSET; BANGLADESH; BEHAVIOR THERAPY; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TOBACCO USE CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO, SMOKELESS; TREATMENT OUTCOME;

EID: 84861948572     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03819.x     Document Type: Article

References (28)

1. Longman J. M., Pritchard C., McNeill A., Csikar J., Croucher R. E. Accessibility of chewing tobacco products in England. J Public Health (Oxf) 2010; 32: 372-8.
2. Critchley J. A., Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003; 58: 435-8.
3. Cancer Research UK, National Cancer Intelligence Network. Cancer Incidence and Survival by Major Ethnic Group, England, 2002-2006 2009. Available at: (accessed 23 March 2011). (Archived by WebCite® at ).
4. International Agency for Research on Cancer. Betel-Quid and Areca-Nut Chewing Ans Some Areca-Nut-Derived Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 85. Lyon, France: World Health Organization, International Agency for Research on Cancer; 2004. Available at: (Archived by WebCite® at ) (accessed 23 March 2011).
5. Nazroo J. Y. The Health of Britain's Ethnic Minorities. London: Policy Studies Institute; 1997.
6. Croucher R., Islam S., Jarvis M., Garrett M., Rahman R., Shajahan S. etal. Tobacco dependence in a UK Bangladeshi female population: a cross-sectional study. Nicotine Tob Res 2002; 4: 171-6.
7. Sproston K., Mindell J. Health Survey for England 2004, vol. 1. The Health of Minority Ethnic Groups. London: The Information Centre; 2006.
8. Marmot M., Ryff C. D., Bumpass L. L., Shipley M., Marks N. E. Social inequalities in health: next questions and converging evidence. Soc Sci Med 1997; 44: 901-10.
9. West R., McNeill A., Raw M. Smokeless tobacco cessation guidelines for health professionals in England. Br Dent J 2004; 196: 611-8.
10. Ebbert J. O., Montori V. M., Erwin P. J., Stead L. F. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2011; (2): CD004306.
11. Boyle R., Severson H., Lichtenstein E., Gordon J. Smokeless tobacco cessation with nicotine reduction. A placebo controlled trial. Paper presented at the 121st Annual Meeting, American Public Health Association; San Francisco, CA; 1992.
12. Allen S. S., Hatsukami D., Jensen J., Grillo M., Bliss R. Effects of behavioural and pharmacological treatment on smokeless tobacco users. J Consult Clin Psychol 1996; 64: 153-61.
13. Howard-Pitney B., Killen J. D., Fortmann S. P. Quitting chew: results from a randomized trial using nicotine patches. Exp Clin Psychopharmacol 1997; 7: 362-71.
14. Hatsukami D., Grillo M., Boyle R., Allen S., Grillo M., Bliss R. etal. Treatment of spit tobacco users with transdermal nicotine system and mint snuff. J Consult Clin Psychol 2000; 68: 241-9.
15. Stotts R. C., Roberson P. K., Hanna E. Y., Jones S. K. A randomized clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents. Tob Control 2003; 12: iv11-5.
16. Ebbert J. O., Dale L. C., Patten C. A., Croghan I. T., Schroeder D. R., Moyer T. P. etal. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine Tob Res 2007; 9: 43-52.
17. Ebbert J. O., Severson H., Croghan I. T., Danaher B. G., Schroeder D. R. A randomized clinical trial of nicotine lozenge for smokeless tobacco use. Nicotine Tob Res 2009; 11: 1415-23.
18. Ebbert J. O., Severson H., Croghan I. T., Danaher B. G., Schroeder D. R. A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users. Addict Behav 2010; 35: 522-5.
19. Croucher R., Islam S., Garrett M., Garrett M., Rahman R., Shajahan S. etal. Oral tobacco cessation with UK resident Bangladeshi women: a community pilot investigation. Health Educ Res 2003; 18: 216-23.
20. Begh R. A., Aveyard P., Upton P. etal. Promoting smoking cessation in Pakistani and Bangladeshi men in the UK: pilot cluster randomised controlled trial of trained community outreach workers. Trials 2011; 12: 197.
21. Michie S., Hyder N., Walia A., Bhopal R. S., White M., Amos A., West R. Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2011; 36: 315-9.
22. Department for Communities and Local Government. Index of Multiple Deprivation. Wetherby: Communities and Local Government Publications; 2007.
23. Heatherton T. F., Koslowski L. T., Frecker R. C., Fagerstrom K. O. The Fagerstrom Test for Nicotine Dependency: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
24. Ebbert J., Patten C. A., Schroeder D. R. The Fagerstrom Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST). Addict Behav 2006; 31: 1716-21.
25. Altman D. G. Practical Statistics for Medical Research. London: Chapman & Hall; 1997.
26. Munro B. H. Statistical Methods for Health Care Research, 5th edn. Philadelphia: Lippincott Williams & Wilkins; 2005.
27. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; (1): CD000146.
28. Lewin S. A., Dick J., Pond P., Zwarenstein M., Aja G., van Wyk B. etal. Lay health workers in primary and community health care: Cochrane Systematic Review. Int J Epidemiol 2005; 34: 1250-1.